Skip to main content
Log in

Antitumor immunity and vaccine effect induced by IL-12 synergizes B7-1 gene transfected cells

  • Articles
  • Published:
Chinese Journal of Cancer Research

Abstract

Objective: To study the synergic effects of IL-12 and B7-1 transfectant on antitumor immunity in vivo. Methods: The retrovirus vector encoding mIL-12 and mB7-1 gene was tranfected into EL-4 thymic lymphoma cells respectively. The cells were used as tumor vaccine and the therapeutic effect was observed. Results: In contrast to the mice immunized with EL-4/Wt or EL-4/Neo groups, the tumorigenicity of EL-4/IL-12 transfectant was decreased (P<0.001). The EL-4/IL-12 and EL-4/B7-1 cells irradiated with 60Co showed significant systematic protective effects against the rechallenge of EL-4/Wt. 60Co irradiated EL-4/IL-12 cells delayed the occurrence of tumor and prolonged the survival period of tumor bearing mice. Combination of the vaccines of EL-4/IL-12 and EL-4/B7-1 resulted in the enhanced therapeutic effect compared with each single transfectant group (P<0.001). Conclusion: The results showed that IL-12 transduced cells could enhance the antitumor immunity of host as cancer vaccine. Combination of the EL-4/IL-12 and EL-4/B7-1 transfectant could improve immunity of host and is a prospect cancer vaccine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tepper RI, Pattengale PK, Leder, P. Murine interleukin-4 displays potent antitumor activity in vivo [J]. Cell 1989; 57:503.

    Article  PubMed  CAS  Google Scholar 

  2. Liger D, Nizard P, Gailard C, et al. The diphtheria toxin transmembrane domain as a pH sensitive membrane anchor for human interleukin-2 and murine interleukin-3 [J]. Protein Eng 1998; 11:1111.

    Article  PubMed  CAS  Google Scholar 

  3. Kim YS, Sonn CH, Paik SG, et al. Tumor cells expressing membrane-bound form of IL-4 induce antitumor immunity [J]. Gene Ther 2000; 7:837.

    Article  PubMed  CAS  Google Scholar 

  4. Lamont AG, Adorini L. IL-12, a key cytokine in immune regulation [J]. Immonl Today 1996; 17:214.

    Article  CAS  Google Scholar 

  5. Uno K, Setoguchi J, Tanigawa M, et al. Differential interleukin 12 responsiveness for interferon gamma production in advanced stages of cancer patients correlates with performance status [J]. Clin Cancer Res 1998; 4:2425.

    PubMed  CAS  Google Scholar 

  6. Gambotto A, Tuting T, McVey DL, et al. Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12 [J]. Cancer Gene Ther 1999; 6:45.

    Article  PubMed  CAS  Google Scholar 

  7. Rakhmilevich AL, Timmins JG, Janssen K, et al. Gene gun-mediated IL-12 gene therapy induces antitumor effects in the absence of toxicity: a direct comparison with systemic IL-12 protein therapy [J]. J Immunother 1999; 22:135.

    Article  PubMed  CAS  Google Scholar 

  8. Slingluff CL Jr, Cox AL, Stover JM Jr, et al. Cytotoxic T-lymphocyte response to autologous human squamous cell cancer of the lung: epitope reconstitution with peptides extracted from HLA-Aw68 [J]. Cancer Res 1994; 54:2731.

    PubMed  CAS  Google Scholar 

  9. Lu L, Hsieh M, Oriss TB, et al. Generation of DC from mouse spleen cell cultures in response to GM-CSF: immunophenotypic and functional analysis [J]. Immunology 1995; 84:127.

    PubMed  CAS  Google Scholar 

  10. Portielje JE, Kruit WH, Schuler M, et al. Phase I study of subcutaneously administered recombinant human interleukin-12 in patients with advanced renal cell cancer [J]. Clin Cancer Res 1999; 5:3983.

    PubMed  CAS  Google Scholar 

  11. Jean WC, Spellman SR, Wallenfriedman MA, et al. Interleukin-12 based immunotherapy against rat 9L glioma [J]. Neurosurgery 1998; 42:850.

    Article  PubMed  CAS  Google Scholar 

  12. Weber SM, Shi F, Heise C, et al. Interleukin-12 gene transfer results in CD8-dependent regression of murine CT26 live tumors [J]. Ann Surg Oncol 1999; 6:186.

    Article  PubMed  CAS  Google Scholar 

  13. Boggio K, Di-Carlo E, Rovero S, et al. Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogensis in HER2/neu transgenic mice [J]. Cancer Res 2000; 60:359.

    PubMed  CAS  Google Scholar 

  14. Trinchieri G. Biological properties and therapeutic application of interleukin-12 [J]. Eur Cytokine Netw 1977; 8:305.

    Google Scholar 

  15. Inaba K, Witmer Pack M, Inaba M, et al. The tissues distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in site and during Maturation in vitro [J]. J Exp Med 1994; 180:1849.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wang Zhi-hua.

Additional information

Foundation item: This work was supported by a grant from the National “95” Key Project of China (No.96-906A-01-20).

Biography: WANG Zhi-hua (1951–), male, professor, Institute of Oncology, Harbin Medical University, majors in tumor immunology and molecular biology.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, Zh., Li, H. & Zhang, Cy. Antitumor immunity and vaccine effect induced by IL-12 synergizes B7-1 gene transfected cells. Chin. J. Cancer Res. 15, 5–8 (2003). https://doi.org/10.1007/s11670-003-0002-6

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11670-003-0002-6

Key words

CLC number

Navigation